France imposes conditions on ventilator product:
This article was originally published in Clinica
Executive Summary
The French healthcare products safety agency, AFSSAPS, has ruled that high frequency oscillation ventilators, SLE 2000 HFO and HFO manufactured by Eurocare (Italy) may only be sold if they are fitted with a compatible flow monitoring system. The new decision, published in the Journal officiel of January 13, follows a series of adverse incident events concerning the lack of reliability of pressure monitoring when the link for the intubation tube is accidentally diconnected and the lack of alarm system in this event.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.